Home › Breast Cancer › NCT05134779
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
RecruitingObservational study
Who can join
Ages 18 to 90 · Women
Full eligibility criteria
Inclusion Criteria: * All patients will historically proven BC are eligible to be on the study Exclusion Criteria: * Carriers of other cancers other than breast.
About the study
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
What is being tested
- Live Biobank (procedure)
Sponsor: Weill Medical College of Cornell University · Participants: 400 · Started: Jan 12, 2022
Contact the study team
- Fabiana Gregucci, M.D. · Phone: 646-962-3110
Official record on ClinicalTrials.gov — NCT05134779
Locations in the U.S.
| New York | Brooklyn Methodist Hospital - NewYork Presbyterian, New York New York Presbyterian Hospital - Queens, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.